Skip to main content
. Author manuscript; available in PMC: 2018 Dec 30.
Published in final edited form as: Angew Chem Int Ed Engl. 2017 Aug 15;56(40):12052–12063. doi: 10.1002/anie.201701065

Figure 6.

Figure 6

Structure of the first clinical entry, E7107 (21), which entered Phase 1 clinical trials for patients with solid tumors. The next-generation analogues 6-deoxypladienolide D (H3B-8800, 22), 17S-FD-895 (23), and cyclopropane 24 are currently being examined for clinical translation for hematologic malignancies. IND=investigational new drug application.